EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Sugar-Linked Diethyldithiocarbamate Derivatives: A Novel Class of Anticancer Agents

Mohammad Najlah iD, Niamh McCallum, Ana Maria Pereira iD, Dan Alves, Niusha Ansari-Fard iD, Sahrish Rehmani iD, Ayşe Kaya

International Journal of Molecular Sciences · 2025

DOI: 10.3390/ijms26125589 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2025. Verfasst von Mohammad Najlah und 6 weiteren Autor:innen. Beteiligte Einrichtung: Pharmaceutical Research Group, School of Allied Health, Faculty of Health, Education, Medicine and Social Care, Anglia Ruskin University, Bishops Hal…. Hauptthemen laut MEDLINE: Antineoplastic Agents, Ditiocarb, Sugars. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 18 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Disulfiram (DSF), a well-known anti-alcoholism drug, exhibits potent anticancer activity via its metabolite, diethyldithiocarbamate (DDC), which forms a cytotoxic copper complex that selectively targets cancer stem cells. However, its clinical utility is limited by poor solubility and rapid plasma metabolism. This study explores saccharide-linked DDCs as novel prodrugs designed to enhance stability, solubility, and tumour-selective activation. These compounds feature thioglycosidic bonds that shield the DDC moiety from premature degradation while retaining its metal-chelating function to form the active copper(II)bis(N,N-diethyldithiocarbamate) (Cu(DDC)2) complex. The synthesised derivatives were characterised and evaluated for serum stability and in vitro cytotoxicity across several cancer cell lines, including colorectal, breast, lung, and brain cancers. Copper-complexed saccharide-DDC prodrugs demonstrated remarkable cytotoxicity, with improved biostability and solubility profiles. These findings highlight the potential of saccharide-linked DDCs as stable, copper-activated prodrugs for cancer therapy. Further in vivo studies are warranted to validate their pharmacokinetics and clinical relevance.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Antineoplastic AgentsDitiocarbSugarsHumansCell Line, TumorCopperProdrugsSolubilityCell SurvivalNeoplasms

Stichwörter der Autor:innen

cancercancer prodrugscopper complexdiethyldithiocarbamate (DDC)disulfirammetal-activated therapysaccharide conjugatesthioglycosidic bond

Substanzen

Antineoplastic AgentsDitiocarbCopperProdrugsSugars

Autor:innen und Institutionen

  • Pharmaceutical Research Group, School of Allied Health, Faculty of Health, Education, Medicine and Social Care, Anglia Ruskin University, Bishops Hall Lane, Chelmsford CM1 1SQ, UK.

ORCID-Profile: Mohammad Najlah, Ana Maria Pereira, Niusha Ansari-Fard, Sahrish Rehmani

Zitieren

APA

Najlah, M., McCallum, N., Pereira, A. M., Alves, D., Ansari-Fard, N., Rehmani, S., & Kaya, A. (2025). Sugar-Linked Diethyldithiocarbamate Derivatives: A Novel Class of Anticancer Agents. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms26125589

Vancouver

Najlah M, McCallum N, Pereira AM, Alves D, Ansari-Fard N, Rehmani S, et al. Sugar-Linked Diethyldithiocarbamate Derivatives: A Novel Class of Anticancer Agents. International Journal of Molecular Sciences. 2025. doi:10.3390/ijms26125589

BibTeX
@article{Najlah2025,
  author = {Najlah, Mohammad and McCallum, Niamh and Pereira, Ana Maria and Alves, Dan and Ansari-Fard, Niusha and Rehmani, Sahrish and Kaya, Ayşe},
  title = {Sugar-Linked Diethyldithiocarbamate Derivatives: A Novel Class of Anticancer Agents},
  journal = {International Journal of Molecular Sciences},
  year = {2025},
  doi = {10.3390/ijms26125589}
}
Kostenlos starten →